Jahnz-Różyk K - Search Results

1

SOSPES: SPIRIVA® observational study measuring SGRQ score in routine medical practice in Central and Eastern Europe.

Fležar M, Jahnz-Różyk K, Enache G, Martynenko T, Kristufek P, Škrinjarić-Cincar S, Kadlecová P, Martinovic G. Fležar M, et al. Int J Chron Obstruct Pulmon Dis. 2013;8:483-92. doi: 10.2147/COPD.S45640. Epub 2013 Oct 9. Int J Chron Obstruct Pulmon Dis. 2013. PMID: 24159258 Free PMC article.

2

Early impact of treatment with tiotropium, long-acting anticholinergic preparation, in patients with COPD - real-life experience from an observational study.

Jahnz-Różyk K, Szepiel P. Jahnz-Różyk K, et al. Int J Chron Obstruct Pulmon Dis. 2015 Mar 18;10:613-23. doi: 10.2147/COPD.S77144. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 25834420 Free PMC article.

3

[Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].

Jahnz-Rózyk K, Targowski T, From S. Jahnz-Rózyk K, et al. Pol Merkur Lekarski. 2009 Mar;26(153):208-14. Pol Merkur Lekarski. 2009. PMID: 19388534 Polish.

4

Analysis of hospital management of chronic respiratory diseases in light of the "Maps of Health Needs" project in Poland.

Jahnz-Różyk K, Czajkowska-Malinowska M, Krenke K, Sands D, Batura-Gabryel H, Kabicz P, Diaków E, Więckowska B. Jahnz-Różyk K, et al. Adv Respir Med. 2020;88(4):297-304. doi: 10.5603/ARM.a2020.0107. Adv Respir Med. 2020. PMID: 32869262 Free article.

5

Facilitated Subcutaneous Immunoglobulin Replacement Therapy in Clinical Practice: A Two Center, Long-Term Retrospective Observation in Adults With Primary Immunodeficiencies.

Wiesik-Szewczyk E, Sołdacki D, Paczek L, Jahnz-Różyk K. Wiesik-Szewczyk E, et al. Front Immunol. 2020 May 20;11:981. doi: 10.3389/fimmu.2020.00981. eCollection 2020. Front Immunol. 2020. PMID: 32670265 Free PMC article.

6

Clinical Determinants of Successful Omalizumab Therapy in Severe Allergic Asthma Patients: 4-Year-Long, Real-Life Observation.

Kucharczyk A, Więsik-Szewczyk E, Poznańska A, Jahnz-Różyk K. Kucharczyk A, et al. J Asthma Allergy. 2020 Dec 14;13:659-668. doi: 10.2147/JAA.S282203. eCollection 2020. J Asthma Allergy. 2020. PMID: 33363390 Free PMC article.

7

Long-term safety of facilitated subcutaneous immunoglobulin treatment in pregnant women with primary immunodeficiency diseases: results from a registry study.

Borte M, Raffac S, Hrubiško M, Jahnz-Rozyk K, Garcia E, McCoy B, Chavan S, Nagy A, Yel L. Borte M, et al. Immunotherapy. 2022 Jun;14(8):609-616. doi: 10.2217/imt-2021-0336. Epub 2022 Apr 20. Immunotherapy. 2022. PMID: 35443783

8

[Today's threat of legionellosis].

Kucharczyk P, Jahnz-Rózyk K. Kucharczyk P, et al. Pol Merkur Lekarski. 2012 Nov;33(197):274-8. Pol Merkur Lekarski. 2012. PMID: 23394039 Review. Polish.

9

The direct costs of drug-induced skin reactions.

Kiepurska N, Paluchowska E, Owczarek W, Szkultecka-Dębek M, Jahnz-Różyk K. Kiepurska N, et al. Ann Agric Environ Med. 2017 May 11;24(2):190-193. doi: 10.5604/12321966.1235168. Ann Agric Environ Med. 2017. PMID: 28664692 Free article.

10

[The costs of asthma in Poland in 2012].

Jahnz-Różyk K, Kucharczyk A, Warchoł M, Radziwilska-Muc A, Władysiuk M, Plisko R. Jahnz-Różyk K, et al. Pol Merkur Lekarski. 2015 Aug;39(230):91-5. Pol Merkur Lekarski. 2015. PMID: 26319382 Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page